HCPCS Level II drug code
J0750 — Emtricitabine 200mg and tenofovir disoproxil fumarate 300mg, oral, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv)
In short
J0750 is the HCPCS Level II code for emtricitabine 200mg and tenofovir disoproxil fumarate 300mg, oral, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv). The Medicare Part B payment limit is $0.451 per unit (October 1, 2026 through December 31, 2026).
Code
CMS HCPCS file- Descriptor
- Emtricitabine 200mg and tenofovir disoproxil fumarate 300mg, oral, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv)
- Short descriptor
- Hiv prep, ftc/tdf 200/300mg
- Code set
- HCPCS Level II, maintained by CMS
- Effective
- Jan 1, 2025
Medicare Part B payment limit
CMS ASP fileEffective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. CMS note: HIV PrEP drug. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files
Units and claim line
Enter the dose to get the units and the NDC line for the CMS-1500 and the 837P.
Enter the units to build the claim line.
Find the NDC
Med-Code hasn’t mapped J0750 to specific products yet. Search the FDA NDC Directory for the drug named in the descriptor, and check the route and strength match the code.
Search NDCs for Emtricitabine 200mg and tenofovir disoproxil fumarate 300mg
J0750: common questions
- Is J0750 a CPT code?
- No. J0750 is a HCPCS Level II code, maintained by CMS, that identifies the drug supplied. CPT codes are five-digit numbers from the AMA that describe services. Giving the drug, for example an injection or infusion, is usually reported with a separate CPT administration code. CPT codes for drug administration.
- What is the Medicare payment limit for J0750?
- $0.451 per 200 mg/300 mg, effective October 1, 2026 through December 31, 2026, from CMS's Part B drug payment limit file. Multiply by the units billed for the allowed amount before deductible and coinsurance. It is not a coverage decision.